Having trouble viewing this email? View in your browser.

29 November 2016

Dear colleagues,

Check out the article about ESCMID and its fight against AMR in the latest government publication by Pan European Networks, which provides information to policy makers at the European Commission, at government agencies and departments across Europe.

ESCMID also published a press release on a paper discussing general practitioners’ vaccination discrepancies published in CMI.

Best regards, your ESCMID communications editors


Abstract submission deadline for ECCMID 2017 is 30 November

Abstract submission for ECCMID from 22 – 25 April 2017 in Vienna is open until Wednesday, 30 November at midnight CET. Share and discuss your research at the largest congress combining clinical microbiology and infectious diseases. To give you some idea about the highlights you can expect next year, you may watch the message of ECCMID Programme Director Winfried Kern.

› Read more

TAE award nomination deadline is 5 January 2017 12.00 CET

The Trainee Association of ESCMID has a new more attractive funding scheme for its TAE award, which is intended to recognize and reward outstanding trainees in clinical microbiology and infectious diseases. The award includes a non-restricted prize money of EUR 1,500, ECCMID 2017 travel and registration and Summer School 2017 registration and accommodation. Find out more about eligibility criteria, the nomination and selection procedure. (Picture: Clíodhna Ní Bhuachalla, winner 2016 TAE award)

› Read more

University laboratory in Brussels seeks new head of clinical microbiology

The University Laboratory of Brussels has an opening for head of the Clinical Microbiology Department. The Head of Department is in charge of the medical, teaching, and administrative organization of the department. The required qualities are leadership and communication skills, rigour and integrity, a sense of responsibility, good resistance to stress, and the ability to prioritize. The Head of Department guarantees and furthers the production of quality results to support hospital clinicians in their daily practice and, in particular, maintains and optimizes the microbiology department's collaboration with the network's infectious diseases hospital departments/wards. He/she represents the microbiology laboratory on the Hospital Hygiene Committee and in the Antibiotic Management Group and ensures the department's collaboration with these bodies while facilitating the transmission of epidemiological and antibiotic resistance data.

› Read more

CMI highlight: Benzylpenicillin in lymphoma and leukaemia

Researchers in Norway compared treating febrile neutropenia (FN) with benzylpenicillin plus an aminoglycoside vs the broad-spectrum beta-lactam antibiotic meropenem in neutropenic patients with lymphoma or leukaemia, and a suspected bacterial infection. Clinical success was significantly more frequent in patients randomized to the meropenem arm, and they also had fewer fatal outcomes than patients randomized to the benzylpenicillin plus an aminoglycoside regimen, the researchers found. Balancing the need for adequate antimicrobial therapy in each patient, and avoiding unnecessary use of broad-spectrum-beta-lactams to reduce antibiotic resistance in the interest of future patients, make this trial and future research important, the researchers conclude.

› Read more
ESCMID Executive Office
P.O. Box 214
4010 Basel
Phone +41 61 5080 173
Visit us on LinkedIn Visit us on YouTube
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.